Capital Markets

Mind Medicine in its $249-million underwritten public offering Mind Medicine in its $249-million underwritten public offering

Mind Medicine (MindMed) Inc.
Key Contact
Trevor R. Scott

Partner, Corporate, Vancouver

Team
Minji Park

Partner, Corporate, Vancouver

Julia McCarty

Associate, Corporate, Vancouver

Kim Maguire

Partner, Tax, Vancouver

On November 3, 2025, Mind Medicine, a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced it closed approximately a $249-million underwritten public offering which includes a full exercise of the underwriter’s option to purchase additional shares.

Osler, Hoskin & Harcourt LLP acted as Canadian counsel to Mind Medicine with a team consisting of Trevor Scott, Minji Park and Julia McCarty (Corporate) and Kim Maguire (Tax).

Value
$249 million
Date Announced
November 3, 2025
Lead Office
Vancouver
Key Contact
Trevor R. Scott

Partner, Corporate, Vancouver

Team
Minji Park

Partner, Corporate, Vancouver

Julia McCarty

Associate, Corporate, Vancouver

Kim Maguire

Partner, Tax, Vancouver